California Public Employees Retirement System’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-12,765
Closed -$1K 3342
2018
Q2
$1K Hold
12,765
﹤0.01% 3288
2018
Q1
$4K Hold
12,765
﹤0.01% 3284
2017
Q4
$21K Hold
12,765
﹤0.01% 3289
2017
Q3
$18K Hold
12,765
﹤0.01% 3316
2017
Q2
$21K Sell
12,765
-1
-0% -$2 ﹤0.01% 3346
2017
Q1
$43K Hold
12,766
﹤0.01% 3330
2016
Q4
$66K Hold
12,766
﹤0.01% 3288
2016
Q3
$322K Hold
12,766
﹤0.01% 2920
2016
Q2
$316K Hold
12,766
﹤0.01% 2946
2016
Q1
$370K Hold
12,766
﹤0.01% 2855
2015
Q4
$474K Buy
+12,766
New +$563K ﹤0.01% 2807
2014
Q1
Sell
-103
Closed -$2K 3945
2013
Q4
$2K Hold
103
﹤0.01% 3963
2013
Q3
$3K Hold
103
﹤0.01% 3955
2013
Q2
$3K Buy
+103
New +$3.84K ﹤0.01% 3957

Other funds holding ANTH

California Public Employees Retirement System's ANTH Position: Q3 2018 in Review

California Public Employees Retirement System sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2018, closing a stake of 12,765 shares — an estimated $1K sold.

California Public Employees Retirement System first reported a position in ANTH in Q2 2013 and held it in 14 quarters. The position peaked at $474K in Q4 2015. 1 fund tracked by Wall St. Rank holds ANTH as of Q3 2018.

  • California Public Employees Retirement System reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • California Public Employees Retirement System sold 12,765 Anthera Pharmaceuticals, Inc. shares in Q3 2018, an estimated $1K.
  • California Public Employees Retirement System first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • California Public Employees Retirement System's Anthera Pharmaceuticals, Inc. position peaked at $474K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2018.

Based on California Public Employees Retirement System's 13F filing for Q3 2018, filed 13 Nov 2018.